Niacinamide — INCI: Niacinamide — is vitamin B3 in its amide form. It is water-soluble, stable across a wide pH range (3.5–7.5), and genuinely one of the most well-researched cosmetic actives available to formulators today. The clinical literature on niacinamide is substantial: studies have demonstrated measurable effects on sebum regulation, post-inflammatory hyperpigmentation, and the appearance of fine lines when used at concentrations between 2% and 10%.
The problem is not the ingredient. The problem is the formulation culture that has grown around it.
The Concentration Myth
Walk into any pharmacy and you will find niacinamide serums ranging from 5% to 20%. The implicit marketing message is that more is better — that a 20% serum is four times as effective as a 5% one. The clinical evidence does not support this. A 2002 study published in the *International Journal of Cosmetic Science* found that 5% niacinamide was effective for reducing hyperpigmentation. Subsequent research has not demonstrated a meaningful dose-response relationship above 10%. At concentrations above 10–15%, some users report flushing — not from the niacinamide itself, but from nicotinic acid, a contaminant present in lower-quality raw material that forms when niacinamide degrades.
"The purity and storage conditions of the raw material are more important than the concentration on the label."
This matters enormously for anyone evaluating products. A well-sourced 5% niacinamide will outperform a poorly sourced 20% product in both efficacy and tolerability.
The Vitamin C Incompatibility — Settled or Not?
The claim that niacinamide and vitamin C (Ascorbic Acid) cannot be used together because they form nicotinic acid has circulated in skincare communities for years. The original concern was based on a 1960s study conducted at elevated temperatures over extended periods — conditions that bear little resemblance to a formulated cosmetic product stored at room temperature.
More recent formulation science suggests that the reaction is negligible under normal cosmetic conditions, provided the product is formulated correctly and stored appropriately. The more practical concern is pH: L-ascorbic acid requires a pH below 3.5 to remain stable and effective, while niacinamide performs best at a higher pH. Combining them in a single formula forces a compromise that benefits neither ingredient.
What the INCI Name Tells You
The INCI name "Niacinamide" is unambiguous — it refers specifically to the amide form of vitamin B3, not nicotinic acid, not niacin. When you see it on an ingredient list, you are looking at a single, well-defined compound. The position in the ingredient list tells you roughly how much is present: ingredients are listed in descending order of concentration above 1%. If niacinamide appears after most of the water-phase ingredients but before the preservative, you are likely looking at a concentration in the 2–5% range.
The Bottom Line
A well-formulated 5% niacinamide serum using a quality raw material source will outperform a poorly formulated 20% product every time. The number on the front of the bottle is marketing. The INCI list is the truth.
Niacinamide and the Skin Barrier
One of the less-marketed but most clinically significant effects of niacinamide is its role in ceramide synthesis. Ceramides are the primary lipid component of the stratum corneum — the outermost layer of the skin that functions as the barrier between the body and the environment. A compromised ceramide profile is associated with conditions including eczema, rosacea, and chronic dryness.
A 2000 study published in the *British Journal of Dermatology* demonstrated that topical niacinamide at 2% increased ceramide levels in the stratum corneum by approximately 34% over a 4-week period. This finding has been replicated in subsequent research and forms the basis for niacinamide's inclusion in barrier-repair formulations alongside ceramides, fatty acids, and cholesterol.
The practical implication is significant: niacinamide is not simply a brightening or anti-sebum ingredient. It is a genuine barrier-support active, which is why it appears in formulations targeting sensitive, reactive, and compromised skin types.
Anti-Inflammatory Mechanisms
Niacinamide's anti-inflammatory activity operates through multiple pathways. It inhibits the transfer of melanosomes from melanocytes to keratinocytes — the mechanism responsible for its hyperpigmentation effects — but it also suppresses the production of pro-inflammatory cytokines including interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-α).
This cytokine suppression is relevant for acne-prone skin. Acne is an inflammatory condition, and while niacinamide does not address the bacterial component (Cutibacterium acnes) directly, its anti-inflammatory activity can reduce the severity of inflammatory lesions. A 2007 study in the *Journal of Cosmetic and Laser Therapy* found that 4% niacinamide gel was as effective as 1% clindamycin gel in reducing inflammatory acne lesions over 8 weeks — a finding that has been cited extensively in dermatological literature.
Sebum Regulation: What the Evidence Actually Shows
The claim that niacinamide reduces sebum production is one of the most repeated in skincare marketing. The evidence is real but nuanced. A 2006 study found that 2% niacinamide reduced sebum excretion rate by approximately 22% over 4 weeks in subjects with oily skin. The mechanism appears to involve inhibition of the enzyme involved in triglyceride synthesis in sebaceous glands.
However, the effect is modest and does not persist after discontinuation. Niacinamide is not a sebostatic agent in the way that isotretinoin is — it does not permanently alter sebaceous gland activity. For individuals with significantly overactive sebaceous glands, niacinamide is a useful adjunct but not a standalone solution.
Hyperpigmentation: Mechanism and Realistic Expectations
Niacinamide's effect on hyperpigmentation is one of its most evidence-backed applications. The mechanism — inhibition of melanosome transfer from melanocytes to keratinocytes — is distinct from the mechanisms of other brightening actives such as L-ascorbic acid (which inhibits tyrosinase) or kojic acid (which chelates copper ions required for tyrosinase activity). This means niacinamide can be combined with these actives for additive brightening effects.
A 2002 study in the *International Journal of Cosmetic Science* found that 5% niacinamide significantly reduced hyperpigmentation and improved skin tone evenness over 8 weeks compared to vehicle control. The effect was visible at 4 weeks and continued to improve through the study period.
Realistic expectations matter here. Niacinamide is not a rapid brightener. The melanosome transfer inhibition mechanism means that existing pigmentation fades as the skin turns over — a process that takes 28–40 days in young skin and longer in older skin. Visible improvement typically requires 8–12 weeks of consistent use at an effective concentration.
Formulation Considerations: pH, Stability, and Delivery
Niacinamide is one of the more forgiving actives from a formulation standpoint. It is stable across a wide pH range (3.5–7.5), water-soluble, and compatible with most other cosmetic ingredients. It does not require special encapsulation or delivery systems to penetrate the stratum corneum, though some formulators use liposomal delivery to increase dermal penetration.
The practical formulation question is pH compatibility with other actives. If a product contains both niacinamide and L-ascorbic acid, the formulator must choose between the optimal pH for vitamin C stability (below 3.5) and the optimal pH for niacinamide (above 4.5). Most dual-active products compromise, which reduces the efficacy of both ingredients. The better approach — used by more sophisticated formulators — is to separate the actives into morning and evening routines.
Reading the INCI List for Niacinamide
When evaluating a product containing niacinamide, the INCI list position is your primary quality signal. Ingredients are listed in descending order of concentration above 1%. If niacinamide appears in the first five ingredients, the concentration is likely above 5%. If it appears after the primary humectants and emollients but before the preservative system, you are probably looking at 2–5%.
Products that list niacinamide after the preservative system — typically Phenoxyethanol or Ethylhexylglycerin — are using it at below 1%, which is insufficient for any of the clinically demonstrated effects. This is a common practice in products that want to feature niacinamide on the front label without committing to an effective concentration.
The presence of Zinc PCA alongside niacinamide is a positive formulation signal for oily or acne-prone skin. Zinc PCA has independent sebum-regulating and anti-inflammatory activity, and the combination has been studied specifically in the context of acne management.
The Bottom Line
Niacinamide is one of the most evidence-backed ingredients in skincare. The research on sebum regulation, hyperpigmentation, barrier function, and anti-inflammatory activity is genuinely strong. But the gap between the clinical evidence and what most products deliver is significant.
A well-formulated 5% niacinamide serum using a quality raw material source will outperform a poorly formulated 20% product every time. The number on the front of the bottle is marketing. The INCI list is the truth.
